Some medicines can affect glucose metabolism and FDG uptake, which may change what a PET scan shows. A 24-hour pause is sometimes recommended, but timing depends on the medication and scan plan. Patients should follow their imaging team’s instructions before changing any prescribed medicine.

Multiple Choice

What is the recommended duration to discontinue certain medications prior to a PET scan?

Discontinuing certain medications prior to a PET scan is essential for ensuring the accuracy of the imaging results. The recommended duration of 24 hours allows for the clearance of medications that may interfere with the uptake of the radiopharmaceuticals used during the scan. Specifically, medications such as sedatives, certain antihyperglycemics, and some psychotropic drugs can influence how the body processes glucose, which is significant since many PET scans are designed to assess metabolic activity through the uptake of FDG, a glucose analogue. By allowing a 24-hour window, most medications will have been metabolized and eliminated from the body to a degree that minimizes their potential effects on the scan. This preparation helps to ensure that the images obtained reflect true physiological conditions rather than altered by external substances. Thus, a discontinuation period of 24 hours is appropriate for maximizing the diagnostic efficacy of the PET scan.

Why Medication Timing Matters Before a PET Scan

A positron emission tomography (PET) scan can show how tissues are working, not just what they look like. That’s what makes it useful in areas such as cancer care, neurology, and cardiology. But the images depend on how a radioactive tracer moves through the body—and some medicines, meals, and health conditions can change that movement. Medication instructions before a scan therefore deserve careful attention.

For many PET studies, the tracer is fluorodeoxyglucose, or FDG. It behaves much like glucose, the sugar cells use for energy. After FDG enters the bloodstream, active cells take it up. A scanner detects the tracer’s signals and turns them into images of metabolic activity. The result can help clinicians assess a tumor, look for signs of infection, or study brain function.

The process sounds straightforward. The body, however, is not a simple diagram. Blood sugar, insulin, muscle activity, and certain medicines can all affect FDG uptake. That’s why preparation matters—and why a single medication rule does not fit every scan or every patient.

The 24-hour window—and what it really means

Some PET instructions call for certain medications to be withheld for about 24 hours before imaging. This interval may be used for drugs that could affect glucose handling or tracer distribution, depending on the scan protocol and the person’s health. Examples may include selected medicines for blood sugar control, sedatives, or psychotropic drugs.

Still, “24 hours” is not a universal rule for all medication. It doesn’t mean every person should stop every medicine for a day. Nor does it guarantee that a drug has fully left the body. Medicines differ in how long they remain active, how the body breaks them down, and whether stopping them could cause harm. A drug’s dose and the patient’s kidney or liver function can matter, too.

The imaging center’s instructions should guide the timing. If the center says a particular medicine needs to be paused, the patient should confirm which dose to skip and when to resume it. If the instructions are unclear, a call to the PET department or prescribing clinician is safer than guessing.

Most importantly, no one should stop a prescribed medicine on their own. Insulin, seizure medicines, heart drugs, steroids, and psychiatric medicines can be risky to change without medical guidance. A scan is valuable, but safe treatment comes first. In many cases, the care team can adjust the scan timing or use a different preparation plan.

Why glucose and insulin get so much attention

FDG’s similarity to glucose is the key to understanding many PET preparation rules. When blood glucose is high, it can compete with FDG for uptake in cells. Insulin also shifts glucose—and FDG—into certain tissues, especially muscle and fat. This may affect how clearly the scan shows the area of interest.

That’s one reason patients may be asked to avoid food for several hours before an FDG PET scan, while drinking plain water is often allowed. Exact fasting instructions vary by facility and scan type. Diabetes adds another layer: fasting and medication changes can affect blood sugar, and an unsafe low or high level can complicate the visit. The imaging team may ask about recent glucose readings and provide a tailored plan.

Not all PET scans use FDG. Other tracers target different biological processes, such as blood flow, bone activity, or specific receptors. A medication that matters for one tracer may not matter for another. So, the name of the scan alone may not tell the whole story; the tracer and purpose of imaging are important.

Medicines can change more than sugar levels

Medication effects are not limited to glucose. A sedative might affect brain activity or reduce movement, which could matter in a study of brain function. Some drugs can influence blood flow, heart rate, or the way tissues absorb a tracer. Others may affect bowel activity or cause muscle tension, potentially changing the pattern seen on an image.

These effects don’t always make a scan unusable. Sometimes they are expected, and the interpreting clinician takes them into account. In other cases, the team may decide that a temporary pause, a change in timing, or a different imaging approach is appropriate. The aim is not to create a “perfect” body for the scanner—nobody arrives as a blank slate—but to understand any factors that could shape the image.

Even recent exercise can affect FDG uptake. Active muscles may absorb more tracer than expected, which is why patients are often asked to avoid strenuous activity before certain scans. The detail can seem small, but it reflects a larger idea: PET images capture the body in a particular moment. What happened in the hours before the scan can leave a visible trace.

A clear medication list makes a difference

Before an appointment, it helps to have a current list of medicines, including prescriptions, over-the-counter products, supplements, and injections. Include the dose and the time each medicine is usually taken. If a drug has recently changed—or if a dose was missed—tell the imaging team.

It’s also worth mentioning allergies, diabetes, pregnancy or breastfeeding, and any recent treatment such as chemotherapy or radiation. These details can affect the choice or timing of imaging. The staff may ask about them more than once; that’s not needless paperwork. It helps the team connect the scan instructions with the person’s actual health needs.

If a patient has already taken a medicine that was supposed to be held, they should say so. Hiding it won’t help the image, and it could lead to an unsafe change in care. The team can decide whether to continue, adjust, or reschedule the scan based on the specific situation.

The practical takeaway

A 24-hour medication pause may be recommended for certain drugs before some PET scans, especially when those drugs could affect glucose use or tracer uptake. But it is a protocol-specific interval, not a blanket instruction. The right plan depends on the medication, the tracer, the scan’s purpose, and the patient’s health.

PET is a powerful way to see biological activity in the body. Its images become more useful when the care team knows what might influence them—and when medication changes are handled safely. Clear instructions, an honest medication list, and a quick call when something is uncertain can make the whole process smoother.